lobbying_activities: 2060804

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2060804	cb211d5e-2f50-420f-bfe4-60dadeea34cb	Q4	NCHC ACTION FUND	401104187	NCHC ACTION FUND	2017	fourth_quarter	PHA	Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D biosimilars	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		10000	0	0	2018-01-11T20:05:33.167000-05:00